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Results Among the 59 included newborns, 47 (79%) had an antenatal diag-
nosis, 31 (52%) received prostaglandins (median duration: 96 h; range 0-192
h), and 38 (65%) underwent a Rashkind procedure. Mean age at surgery was
5±2 days. The mortality rate was 5% (n=3). Younger age at surgery signifi-
cantly increased the probability to be extubated within 2 days after surgery,
both in univariate analysis (Odd ratio 0.64; confidence interval 0.44-0.92)
(p=0.01) and after adjustment for preoperative characteristics and management
(OR 0.61; CI 0.39-0.95) (p=0.03). The presence of coronary anomalies tended
to increase time to extubation, whereas Rashkind procedure and prostaglandin
treatment had no impact. 
Conclusion Our study shows that younger age at surgery is associated with
lower postoperative morbidity in newborns undergoing an ASO. These find-
ings suggest that early surgery is preferable to delay with palliative manage-
ment such as Rashkind and/or Prostaglandins. 
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Background Persistant fetal tachycardias, especially when complicated
with hydrops, are associated with a poor prognosis. Digoxin and flecaine are
usually used but not always effective. Amiodarone remains frequently a last
choice of treatment because of its known complications. 
Aims In this retrospective study, we reviewed the use of amiodarone in
patients with resistant fetal tachycardia, to determine the safety of this drug
and its efficiency. 
Methods Between 1986 and 2012, sixteen pregnancies admitted for fetal
tachycardia were treated with amiodarone. Four had atrial flutter and twelve
had supra-ventricular tachycardia. The fetuses were severe: ten fetuses (63%)
had hydrops. Amiodarone was never used as a first line therapy, but as a
second line therapy in 6 fetuses and as a third line therapy in 6 fetuses. 
Results Amiodarone was effective in 10 of the 16 (63%) patients and despite
the presence of hydrops (efficiency was obtained in 4/6 fetuses of the non
hydropic group versus 6/10 of the hydrops group, p=NS). Among mothers, two
complications were noticed: mild hypothyroidism and hepatic cytolysis. Hypothy-
roidism was present in three patients who did not need any substitutive treatment.
Hepatic cytolysis was also present in three patients but never above three times
normal level. Fetuses were born at 35.8±3.2 WA, weighed 2805±579g, and five
of them required oral intubation at birth. One fetal death occured (sinusal rhythm
was obtained but hydrops with ventricular dysfunction persisted and a ventricular
thrombus appeared). Hypothyroidism was present in six patients: three had tran-
sient hypothyroidism that resolved in two weeks, two were treated for six months
and one is still treated. All children had normal neurological development. 
Conclusion Persistant tachycardias complicated with hydrops remain a
medical challenge. Amiodarone seems to be a safe and efficient alternative
drug in this indication. 
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Congenital heart disease (CHD) is a common cause of infant mortality. They
arecharacterized by a wide variety of anatomic lesions which require early diag-
nosis and corrective surgery. The operative result depends of infrastructure,
medical and paramedical staff. Our aim is to evaluate the impact of polyvalent
pediatric intensive care unit on patients operated for CHD. This is a retrospec-
tive study over a period of 3years (2011-2013), which included 71 patients
admitted in polyvalent pediatric intensive cre unit in the immediate postopera-
tive of a curative or palliative surgery for congenital heart disease. Median age:
15 months, 52% female, 35.2% were hypotrophic, genetic abnormality in
14.1%. The left-right shunt in 63.4%. A delay time of surgery in 42.2%. Cura-
tive surgical treatment in 64.8%. Post-operative complication in 37.7% (infec-
tious complication in 35%, hemodynamics complication in 30%, respiratory
complication in 22.5%, neurological in 2.5%) hospital mortality 9,6%. median
time between surgery and death was 3 days (2,5H-15 days). The median lenght
of stay: 4 days (2,5H-60 days). It’s concluded that despite receving patients
in polyvalent pediatric intensive care unit, the result would be interesting for a
developping country in term of strategy to improve the managment of CHD.
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Introduction One of the key success factors of the surgical treatment of
complex congenital heart defects is a detailed preoperative exploration. The
main issue is the lack of detailed visibility of the intracardiac anatomical struc-
tures. 2D echocardiography provides a partial view and doesn’t provide fine
anatomical details. Novel imagery technology with 3D cardiac tomography (CT)
may represent a valuable tool to explore complex congenital heart defects.
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Abstract 0217 – Figure: Velocity curves with/without heart rate variation
